Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Parkinson's Disease Drug market report explains the definition, types, applications, major countries, and major players of the Parkinson's Disease Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Stada Arzneimittel
Apokyn
Orion
US WorldMeds
Abbvie
Endo Pharmaceuticals
Boehringer Ingelheim
FHoffmann-La Roche
Astellas Pharma
Merck
Novartis
Kyowa Hakko Kirin Pharma
Valeant Pharmaceuticals
Teva Pharmaceutical
Valeant
Akorn
GSK
Desitin Arzneimittel
Teva Pharmaceutical Pharmaceuticals
By Type:
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other
By End-User:
Under 40 Years Old
40-65 Years Old
Above 65 Years Old
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Parkinson's Disease Drug Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Parkinson's Disease Drug Outlook to 2028- Original Forecasts
-
2.2 Parkinson's Disease Drug Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Parkinson's Disease Drug Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Parkinson's Disease Drug Market- Recent Developments
-
6.1 Parkinson's Disease Drug Market News and Developments
-
6.2 Parkinson's Disease Drug Market Deals Landscape
7 Parkinson's Disease Drug Raw Materials and Cost Structure Analysis
-
7.1 Parkinson's Disease Drug Key Raw Materials
-
7.2 Parkinson's Disease Drug Price Trend of Key Raw Materials
-
7.3 Parkinson's Disease Drug Key Suppliers of Raw Materials
-
7.4 Parkinson's Disease Drug Market Concentration Rate of Raw Materials
-
7.5 Parkinson's Disease Drug Cost Structure Analysis
-
7.5.1 Parkinson's Disease Drug Raw Materials Analysis
-
7.5.2 Parkinson's Disease Drug Labor Cost Analysis
-
7.5.3 Parkinson's Disease Drug Manufacturing Expenses Analysis
8 Global Parkinson's Disease Drug Import and Export Analysis (Top 10 Countries)
-
8.1 Global Parkinson's Disease Drug Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Parkinson's Disease Drug Export by Region (Top 10 Countries) (2017-2028)
9 Global Parkinson's Disease Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Parkinson's Disease Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Sinemet-CR Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Trastal Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Madopar Consumption and Growth Rate (2017-2022)
-
9.1.4 Global COMT Inhibitor Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Parkinson's Disease Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Under 40 Years Old Consumption and Growth Rate (2017-2022)
-
9.2.2 Global 40-65 Years Old Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Above 65 Years Old Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Parkinson's Disease Drug Market Analysis and Outlook till 2022
-
10.1 Global Parkinson's Disease Drug Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Parkinson's Disease Drug Consumption (2017-2022)
-
10.2.2 Canada Parkinson's Disease Drug Consumption (2017-2022)
-
10.2.3 Mexico Parkinson's Disease Drug Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Parkinson's Disease Drug Consumption (2017-2022)
-
10.3.2 UK Parkinson's Disease Drug Consumption (2017-2022)
-
10.3.3 Spain Parkinson's Disease Drug Consumption (2017-2022)
-
10.3.4 Belgium Parkinson's Disease Drug Consumption (2017-2022)
-
10.3.5 France Parkinson's Disease Drug Consumption (2017-2022)
-
10.3.6 Italy Parkinson's Disease Drug Consumption (2017-2022)
-
10.3.7 Denmark Parkinson's Disease Drug Consumption (2017-2022)
-
10.3.8 Finland Parkinson's Disease Drug Consumption (2017-2022)
-
10.3.9 Norway Parkinson's Disease Drug Consumption (2017-2022)
-
10.3.10 Sweden Parkinson's Disease Drug Consumption (2017-2022)
-
10.3.11 Poland Parkinson's Disease Drug Consumption (2017-2022)
-
10.3.12 Russia Parkinson's Disease Drug Consumption (2017-2022)
-
10.3.13 Turkey Parkinson's Disease Drug Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Parkinson's Disease Drug Consumption (2017-2022)
-
10.4.2 Japan Parkinson's Disease Drug Consumption (2017-2022)
-
10.4.3 India Parkinson's Disease Drug Consumption (2017-2022)
-
10.4.4 South Korea Parkinson's Disease Drug Consumption (2017-2022)
-
10.4.5 Pakistan Parkinson's Disease Drug Consumption (2017-2022)
-
10.4.6 Bangladesh Parkinson's Disease Drug Consumption (2017-2022)
-
10.4.7 Indonesia Parkinson's Disease Drug Consumption (2017-2022)
-
10.4.8 Thailand Parkinson's Disease Drug Consumption (2017-2022)
-
10.4.9 Singapore Parkinson's Disease Drug Consumption (2017-2022)
-
10.4.10 Malaysia Parkinson's Disease Drug Consumption (2017-2022)
-
10.4.11 Philippines Parkinson's Disease Drug Consumption (2017-2022)
-
10.4.12 Vietnam Parkinson's Disease Drug Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Parkinson's Disease Drug Consumption (2017-2022)
-
10.5.2 Colombia Parkinson's Disease Drug Consumption (2017-2022)
-
10.5.3 Chile Parkinson's Disease Drug Consumption (2017-2022)
-
10.5.4 Argentina Parkinson's Disease Drug Consumption (2017-2022)
-
10.5.5 Venezuela Parkinson's Disease Drug Consumption (2017-2022)
-
10.5.6 Peru Parkinson's Disease Drug Consumption (2017-2022)
-
10.5.7 Puerto Rico Parkinson's Disease Drug Consumption (2017-2022)
-
10.5.8 Ecuador Parkinson's Disease Drug Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Parkinson's Disease Drug Consumption (2017-2022)
-
10.6.2 Kuwait Parkinson's Disease Drug Consumption (2017-2022)
-
10.6.3 Oman Parkinson's Disease Drug Consumption (2017-2022)
-
10.6.4 Qatar Parkinson's Disease Drug Consumption (2017-2022)
-
10.6.5 Saudi Arabia Parkinson's Disease Drug Consumption (2017-2022)
-
10.6.6 United Arab Emirates Parkinson's Disease Drug Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Parkinson's Disease Drug Consumption (2017-2022)
-
10.7.2 South Africa Parkinson's Disease Drug Consumption (2017-2022)
-
10.7.3 Egypt Parkinson's Disease Drug Consumption (2017-2022)
-
10.7.4 Algeria Parkinson's Disease Drug Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Parkinson's Disease Drug Consumption (2017-2022)
-
10.8.2 New Zealand Parkinson's Disease Drug Consumption (2017-2022)
11 Global Parkinson's Disease Drug Competitive Analysis
-
11.1 Stada Arzneimittel
-
11.1.1 Stada Arzneimittel Company Details
-
11.1.2 Stada Arzneimittel Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Stada Arzneimittel Parkinson's Disease Drug Main Business and Markets Served
-
11.1.4 Stada Arzneimittel Parkinson's Disease Drug Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Apokyn
-
11.2.1 Apokyn Company Details
-
11.2.2 Apokyn Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Apokyn Parkinson's Disease Drug Main Business and Markets Served
-
11.2.4 Apokyn Parkinson's Disease Drug Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Orion
-
11.3.1 Orion Company Details
-
11.3.2 Orion Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Orion Parkinson's Disease Drug Main Business and Markets Served
-
11.3.4 Orion Parkinson's Disease Drug Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 US WorldMeds
-
11.4.1 US WorldMeds Company Details
-
11.4.2 US WorldMeds Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 US WorldMeds Parkinson's Disease Drug Main Business and Markets Served
-
11.4.4 US WorldMeds Parkinson's Disease Drug Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Abbvie
-
11.5.1 Abbvie Company Details
-
11.5.2 Abbvie Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Abbvie Parkinson's Disease Drug Main Business and Markets Served
-
11.5.4 Abbvie Parkinson's Disease Drug Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Endo Pharmaceuticals
-
11.6.1 Endo Pharmaceuticals Company Details
-
11.6.2 Endo Pharmaceuticals Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Endo Pharmaceuticals Parkinson's Disease Drug Main Business and Markets Served
-
11.6.4 Endo Pharmaceuticals Parkinson's Disease Drug Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Boehringer Ingelheim
-
11.7.1 Boehringer Ingelheim Company Details
-
11.7.2 Boehringer Ingelheim Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Boehringer Ingelheim Parkinson's Disease Drug Main Business and Markets Served
-
11.7.4 Boehringer Ingelheim Parkinson's Disease Drug Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 FHoffmann-La Roche
-
11.8.1 FHoffmann-La Roche Company Details
-
11.8.2 FHoffmann-La Roche Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 FHoffmann-La Roche Parkinson's Disease Drug Main Business and Markets Served
-
11.8.4 FHoffmann-La Roche Parkinson's Disease Drug Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Astellas Pharma
-
11.9.1 Astellas Pharma Company Details
-
11.9.2 Astellas Pharma Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Astellas Pharma Parkinson's Disease Drug Main Business and Markets Served
-
11.9.4 Astellas Pharma Parkinson's Disease Drug Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Merck
-
11.10.1 Merck Company Details
-
11.10.2 Merck Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Merck Parkinson's Disease Drug Main Business and Markets Served
-
11.10.4 Merck Parkinson's Disease Drug Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Novartis
-
11.11.1 Novartis Company Details
-
11.11.2 Novartis Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Novartis Parkinson's Disease Drug Main Business and Markets Served
-
11.11.4 Novartis Parkinson's Disease Drug Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Kyowa Hakko Kirin Pharma
-
11.12.1 Kyowa Hakko Kirin Pharma Company Details
-
11.12.2 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Main Business and Markets Served
-
11.12.4 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Valeant Pharmaceuticals
-
11.13.1 Valeant Pharmaceuticals Company Details
-
11.13.2 Valeant Pharmaceuticals Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Valeant Pharmaceuticals Parkinson's Disease Drug Main Business and Markets Served
-
11.13.4 Valeant Pharmaceuticals Parkinson's Disease Drug Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Teva Pharmaceutical
-
11.14.1 Teva Pharmaceutical Company Details
-
11.14.2 Teva Pharmaceutical Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Teva Pharmaceutical Parkinson's Disease Drug Main Business and Markets Served
-
11.14.4 Teva Pharmaceutical Parkinson's Disease Drug Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Valeant
-
11.15.1 Valeant Company Details
-
11.15.2 Valeant Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Valeant Parkinson's Disease Drug Main Business and Markets Served
-
11.15.4 Valeant Parkinson's Disease Drug Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Akorn
-
11.16.1 Akorn Company Details
-
11.16.2 Akorn Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Akorn Parkinson's Disease Drug Main Business and Markets Served
-
11.16.4 Akorn Parkinson's Disease Drug Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 GSK
-
11.17.1 GSK Company Details
-
11.17.2 GSK Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 GSK Parkinson's Disease Drug Main Business and Markets Served
-
11.17.4 GSK Parkinson's Disease Drug Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Desitin Arzneimittel
-
11.18.1 Desitin Arzneimittel Company Details
-
11.18.2 Desitin Arzneimittel Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Desitin Arzneimittel Parkinson's Disease Drug Main Business and Markets Served
-
11.18.4 Desitin Arzneimittel Parkinson's Disease Drug Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Teva Pharmaceutical Pharmaceuticals
-
11.19.1 Teva Pharmaceutical Pharmaceuticals Company Details
-
11.19.2 Teva Pharmaceutical Pharmaceuticals Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Teva Pharmaceutical Pharmaceuticals Parkinson's Disease Drug Main Business and Markets Served
-
11.19.4 Teva Pharmaceutical Pharmaceuticals Parkinson's Disease Drug Product Portfolio
-
11.19.5 Recent Research and Development Strategies
12 Global Parkinson's Disease Drug Market Outlook by Types and Applications to 2028
-
12.1 Global Parkinson's Disease Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Sinemet-CR Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Trastal Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Madopar Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global COMT Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Parkinson's Disease Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Under 40 Years Old Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global 40-65 Years Old Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Above 65 Years Old Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Parkinson's Disease Drug Market Analysis and Outlook to 2028
-
13.1 Global Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.2.2 Canada Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.2.3 Mexico Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.3.2 UK Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.3.3 Spain Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.3.4 Belgium Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.3.5 France Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.3.6 Italy Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.3.7 Denmark Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.3.8 Finland Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.3.9 Norway Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.3.10 Sweden Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.3.11 Poland Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.3.12 Russia Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.3.13 Turkey Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.4.2 Japan Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.4.3 India Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.4.4 South Korea Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.4.8 Thailand Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.4.9 Singapore Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.4.11 Philippines Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.5.2 Colombia Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.5.3 Chile Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.5.4 Argentina Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.5.6 Peru Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.6.3 Oman Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.6.4 Qatar Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.7.2 South Africa Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.7.3 Egypt Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.7.4 Algeria Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Parkinson's Disease Drug Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Parkinson's Disease Drug Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Parkinson's Disease Drug
-
Figure of Parkinson's Disease Drug Picture
-
Table Global Parkinson's Disease Drug Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Parkinson's Disease Drug Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Sinemet-CR Consumption and Growth Rate (2017-2022)
-
Figure Global Trastal Consumption and Growth Rate (2017-2022)
-
Figure Global Madopar Consumption and Growth Rate (2017-2022)
-
Figure Global COMT Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Under 40 Years Old Consumption and Growth Rate (2017-2022)
-
Figure Global 40-65 Years Old Consumption and Growth Rate (2017-2022)
-
Figure Global Above 65 Years Old Consumption and Growth Rate (2017-2022)
-
Figure Global Parkinson's Disease Drug Consumption by Country (2017-2022)
-
Table North America Parkinson's Disease Drug Consumption by Country (2017-2022)
-
Figure United States Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Canada Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Mexico Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Parkinson's Disease Drug Consumption by Country (2017-2022)
-
Figure Germany Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure UK Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Spain Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Belgium Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure France Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Italy Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Denmark Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Finland Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Norway Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Sweden Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Poland Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Russia Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Turkey Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Table APAC Parkinson's Disease Drug Consumption by Country (2017-2022)
-
Figure China Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure India Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Thailand Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Singapore Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Philippines Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Table South America Parkinson's Disease Drug Consumption by Country (2017-2022)
-
Figure Brazil Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Colombia Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Chile Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Argentina Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Peru Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Table GCC Parkinson's Disease Drug Consumption by Country (2017-2022)
-
Figure Bahrain Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Oman Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Qatar Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Table Africa Parkinson's Disease Drug Consumption by Country (2017-2022)
-
Figure Nigeria Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure South Africa Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Egypt Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Algeria Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Table Oceania Parkinson's Disease Drug Consumption by Country (2017-2022)
-
Figure Australia Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Parkinson's Disease Drug Consumption and Growth Rate (2017-2022)
-
Table Stada Arzneimittel Company Details
-
Table Stada Arzneimittel Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Stada Arzneimittel Parkinson's Disease Drug Main Business and Markets Served
-
Table Stada Arzneimittel Parkinson's Disease Drug Product Portfolio
-
Table Apokyn Company Details
-
Table Apokyn Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Apokyn Parkinson's Disease Drug Main Business and Markets Served
-
Table Apokyn Parkinson's Disease Drug Product Portfolio
-
Table Orion Company Details
-
Table Orion Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Orion Parkinson's Disease Drug Main Business and Markets Served
-
Table Orion Parkinson's Disease Drug Product Portfolio
-
Table US WorldMeds Company Details
-
Table US WorldMeds Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table US WorldMeds Parkinson's Disease Drug Main Business and Markets Served
-
Table US WorldMeds Parkinson's Disease Drug Product Portfolio
-
Table Abbvie Company Details
-
Table Abbvie Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbvie Parkinson's Disease Drug Main Business and Markets Served
-
Table Abbvie Parkinson's Disease Drug Product Portfolio
-
Table Endo Pharmaceuticals Company Details
-
Table Endo Pharmaceuticals Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Endo Pharmaceuticals Parkinson's Disease Drug Main Business and Markets Served
-
Table Endo Pharmaceuticals Parkinson's Disease Drug Product Portfolio
-
Table Boehringer Ingelheim Company Details
-
Table Boehringer Ingelheim Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Parkinson's Disease Drug Main Business and Markets Served
-
Table Boehringer Ingelheim Parkinson's Disease Drug Product Portfolio
-
Table FHoffmann-La Roche Company Details
-
Table FHoffmann-La Roche Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table FHoffmann-La Roche Parkinson's Disease Drug Main Business and Markets Served
-
Table FHoffmann-La Roche Parkinson's Disease Drug Product Portfolio
-
Table Astellas Pharma Company Details
-
Table Astellas Pharma Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Parkinson's Disease Drug Main Business and Markets Served
-
Table Astellas Pharma Parkinson's Disease Drug Product Portfolio
-
Table Merck Company Details
-
Table Merck Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Parkinson's Disease Drug Main Business and Markets Served
-
Table Merck Parkinson's Disease Drug Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Parkinson's Disease Drug Main Business and Markets Served
-
Table Novartis Parkinson's Disease Drug Product Portfolio
-
Table Kyowa Hakko Kirin Pharma Company Details
-
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Main Business and Markets Served
-
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Product Portfolio
-
Table Valeant Pharmaceuticals Company Details
-
Table Valeant Pharmaceuticals Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Pharmaceuticals Parkinson's Disease Drug Main Business and Markets Served
-
Table Valeant Pharmaceuticals Parkinson's Disease Drug Product Portfolio
-
Table Teva Pharmaceutical Company Details
-
Table Teva Pharmaceutical Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Parkinson's Disease Drug Main Business and Markets Served
-
Table Teva Pharmaceutical Parkinson's Disease Drug Product Portfolio
-
Table Valeant Company Details
-
Table Valeant Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Parkinson's Disease Drug Main Business and Markets Served
-
Table Valeant Parkinson's Disease Drug Product Portfolio
-
Table Akorn Company Details
-
Table Akorn Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Akorn Parkinson's Disease Drug Main Business and Markets Served
-
Table Akorn Parkinson's Disease Drug Product Portfolio
-
Table GSK Company Details
-
Table GSK Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Parkinson's Disease Drug Main Business and Markets Served
-
Table GSK Parkinson's Disease Drug Product Portfolio
-
Table Desitin Arzneimittel Company Details
-
Table Desitin Arzneimittel Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Desitin Arzneimittel Parkinson's Disease Drug Main Business and Markets Served
-
Table Desitin Arzneimittel Parkinson's Disease Drug Product Portfolio
-
Table Teva Pharmaceutical Pharmaceuticals Company Details
-
Table Teva Pharmaceutical Pharmaceuticals Parkinson's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Pharmaceuticals Parkinson's Disease Drug Main Business and Markets Served
-
Table Teva Pharmaceutical Pharmaceuticals Parkinson's Disease Drug Product Portfolio
-
Figure Global Sinemet-CR Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Trastal Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Madopar Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global COMT Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Under 40 Years Old Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 40-65 Years Old Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Above 65 Years Old Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Parkinson's Disease Drug Consumption Forecast by Country (2022-2028)
-
Table North America Parkinson's Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Parkinson's Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure Germany Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Parkinson's Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure China Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Parkinson's Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure Brazil Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Parkinson's Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Parkinson's Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Parkinson's Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure Australia Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Parkinson's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
